New shot could soothe severe eczema in teens
NCT ID NCT07540442
First seen Apr 28, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study tests an experimental drug called MG-K10 in 180 teenagers with moderate-to-severe atopic dermatitis (eczema). The drug is a lab-made antibody given as an injection, and it aims to reduce skin redness, itching, and rash. Participants will receive either MG-K10 or a placebo, and neither they nor their doctors will know which. The main goals are to see if the drug clears or greatly improves the skin and eases itching, while checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Hospital Of China Medical University
Shenyang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.